Is it necessary to separate clinical stage T1c from T2 prostate adenocarcinoma?
- 1 October 2005
- journal article
- Published by Wiley in BJU International
- Vol. 96 (6), 777-780
- https://doi.org/10.1111/j.1464-410x.2005.05713.x
Abstract
To test the hypothesis that prostate cancer patients with clinical stage cT1c and cT2 have similar outcomes and clinicopathological features, and should be grouped together. From a series of men with prostate cancer who had a radical retropubic prostatectomy (RP), we assessed those with cT1c (223) and cT2 (65) adenocarcinoma. All RP specimens were totally embedded and whole-mounted; tumour volume was measured using the grid method. Clinical and pathological characteristics were analysed. Patients with cT2 tumours were more likely to have a higher Gleason score (P = 0.04) and final pathological stage (P = 0.05) than those with cT1c tumours. There was no significant difference in age (P = 0.92), preoperative PSA level (P = 0.17), prostate weight (P = 0.34), tumour volume (P = 0.16), surgical margin status (P = 0.86), multifocality (P = 0.92), the presence of perineural invasion (P = 0.09), or high-grade prostatic intraepithelial neoplasia (P = 0.99) between patients with clinical stage cT1c and those with cT2 tumours. There was no difference in PSA recurrence between patients with clinical stage T1c and those with cT2 tumours (P = 0.27). Patients with clinical stage cT2 tumours have a higher Gleason score and advanced pathological stage than tumours detected because of a high serum PSA level (cT1c). These results suggest that clinical stage cT1c tumours should be separated from clinical stage cT2 disease, but the PSA recurrence rate for both tumour stages is similar, indicating a need for further evaluation and refinement of the current clinical staging system.Keywords
This publication has 26 references indexed in Scilit:
- The Combined Percentage of Gleason Patterns 4 and 5 Is the Best Predictor of Cancer Progression After Radical ProstatectomyJournal of Clinical Oncology, 2005
- Preoperative prediction of Gleason grade in radical prostatectomy specimens: the influence of different Gleason grades from multiple positive biopsy sitesLaboratory Investigation, 2005
- Improved Clinical Staging System Combining Biopsy Laterality and TNM Stage for Men With T1c and T2 Prostate Cancer: Results From the SEARCH DatabaseJournal of Urology, 2003
- CHARACTERIZATION AND PREDICTORS OF PROSTATE SPECIFIC ANTIGEN PROGRESSION RATES AFTER RADICAL RETROPUBIC PROSTATECTOMYJournal of Urology, 2000
- CLINICAL AND PATHOLOGICAL CHARACTERISTICS, AND RECURRENCE RATES OF STAGE T1C VERSUS T2A OR T2B PROSTATE CANCERJournal of Urology, 1999
- COMPARISON OF DIGITAL RECTAL EXAMINATION AND BIOPSY RESULTS WITH THE RADICAL PROSTATECTOMY SPECIMENJournal of Urology, 1999
- HISTOLOGICAL AND CLINICAL FINDINGS IN 896 CONSECUTIVE PROSTATES TREATED ONLY WITH RADICAL RETROPUBIC PROSTATECTOMYJournal of Urology, 1998
- Prostate Specific Antigen Detected Prostate Cancer (Clinical Stage T1C)Journal of Urology, 1996
- PSA‐detected prostate cancer: Contrasts with palpable diseaseJournal of Surgical Oncology, 1995
- Positive Margins after Radical Prostatectomy: Correlation with Local Recurrence and Distant ProgressionBritish Journal of Urology, 1993